Clinical Trial Update: Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of docetaxel and irinotecan in patients with advanced esophageal or gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED